Maplelane Capital’s Celgene Corp CELG Stock Holding History

Maplelane Capital’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-125,000	Closed	-$11.2M	–	217
2018 Q1	$11.2M	Buy	+125,000	New	+$12M	0.29%	83

Other funds holding CELG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Maplelane Capital's CELG Position: Q2 2018 in Review

Maplelane Capital sold out of Celgene Corp (CELG) in Q2 2018, closing a stake of 1 share.

Maplelane Capital first reported a position in CELG in Q1 2018 and held it in 1 quarter. The position peaked at $0 in Q1 2018. 1,360 funds tracked by Wall St. Rank hold CELG as of Q2 2018.

Maplelane Capital reported no remaining Celgene Corp position as of Q2 2018 after selling out during the quarter.
Maplelane Capital sold 1 Celgene Corp share in Q2 2018.
Maplelane Capital first reported a position in Celgene Corp in Q1 2018 and held it in 1 quarter.
Maplelane Capital's Celgene Corp position peaked at $0 in Q1 2018.
1,360 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2018.

Based on Maplelane Capital's 13F filing for Q2 2018, filed 13 Aug 2018.